PhRMA Urges Antitrust Exemption For Bioterrorism Research
Executive Summary
An antitrust exemption to allow pharmaceutical companies to share production techniques for bioterrorism countermeasures will speed development of necessary agents, the Pharmaceutical Research & Manufacturers of America says